Compliance -57 (5)
Compliance-57 (5): intimation after the end of quarter
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Compliance-57 (4): Prior intimation to the beginning of the quarter
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Transgene Biotek Limited. Press Release Dec 30 2025
- Shareholder Meeting / Postal Ballot-Outcome of AGM
Later from Transgene Biotek
- Statement Of Deviation & Variation
- Transgene Biotek Limited. Press Release Jan 12 2026
- Declaration Under Clause 36 Of Listing Agreement With BSEPROHIBITORY ORDER NO. RRD/SRO/1166/2026/1 - SEBI
- Transgene Biotek Limited. Press Release Feb 03 2026
- Board Meeting Outcome for Outcome Of Board Meeting
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek